Influence of Family History of Diabetes on Incidence and Prevalence of Latent Autoimmune Diabetes of the Adult

Results from the Nord-Trøndelag Health Study

  1. Sofia Carlsson, PHD1,
  2. Kristian Midthjell, MD, PHD2 and
  3. Valdemar Grill, MD, PHD3
  1. 1Division of Epidemiology, Stockholm Centre of Public Health and Department of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  2. 2Nord-Trøndelag Health Study Research Centre, Department of Community Medicine and General Practice, Norwegian University of Science and Technology
  3. 3Norwegian University of Science and Technology Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology and Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
  1. Address correspondence and reprint requests to Sofia Carlsson, Division of Epidemiology, Norrbacka, S-171 76 Stockholm, Sweden. E-mail: sofia.carlsson{at}ki.se

Abstract

OBJECTIVE—The aim of this study was to investigate the association between family history of diabetes (FHD) and prevalence and incidence of latent autoimmune diabetes of the adult (LADA), type 1 diabetes, and type 2 diabetes.

RESEARCH DESIGN AND METHODS—The results were based on cross-sectional data from 64,498 men and women (aged ≥20 years) who were in the Nord-Trøndelag Health Study, which included 128 cases of LADA, 1,134 cases of type 2 diabetes, and 123 cases of type 1 diabetes. In addition, prospective data on 46,210 subjects, which included 80 incident cases of LADA, observed between 1984 and 1986 and 1995 and 1997 were available. Patients with LADA had antibodies against GAD and were insulin independent at diagnosis.

RESULTS—FHD was associated with a four times (odds ratio [OR] 3.92 [95% CI 2.76–5.58]) increased prevalence of LADA. Corresponding estimates for type 2 and type 1 diabetes were 4.2 (3.72–4.75) and 2.78 (1.89–4.10), respectively. Patients with LADA who had FHD had lower levels of C-peptide (541 vs. 715 pmol/l) and were more often treated with insulin (47 vs. 31%) than patients without FHD. Prospective data indicated that subjects with siblings who had diabetes had a 2.5 (1.39–4.51) times increased risk of developing LADA during the 11-year follow-up compared with those without.

CONCLUSIONS—This study indicates that FHD is a strong risk factor for LADA and that the influence of family history may be mediated through a heritable reduction of insulin secretion.

Footnotes

  • Published ahead of print at http://care.diabetesjournals.org on 18 September 2007. DOI: 10.2337/dc07-0718.

    A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    • Accepted September 12, 2007.
    • Received April 12, 2007.
| Table of Contents

This Article

  1. Diabetes Care vol. 30 no. 12 3040-3045
  1. All Versions of this Article:
    1. dc07-0718v1
    2. 30/12/3040 most recent